Clinical Trials Browser

Interventional × Primary Breast Cancer × CP protocol × Clear all

NCT01314833 2020-05-19

Minus Anthracycline or Short-Term Versus Epirubicin and Cyclophosphamide Followed by Paclitaxel Regimen for Adjuvant Breast Cancer Therapy

Phase 3 Completed

Primary Breast Cancer